The market repriced a €500bn monopoly on a programme that has been public since September. The earnings path has not moved: EPS compounds 2.6x by 2028
The market repriced a €500bn monopoly on a programme that has been public since September. The earnings path has not moved: EPS compounds 2.6x by 2028
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.